| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.9 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.004 | 0.9 |